Improved Quality of the Treatment and Increased Compliance in Asthmatics Through the Dialog Tool Soren - Between Patient and Caregiver

Not Applicable

Completed

• Conditions: Asthma

• Registration Number: NCT00272727
• Lead Sponsor: AstraZeneca

Brief Summary

The purpose of the study is to assess if a dialog tool can improve compliance and asthma control in patients with asthma.

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2006-01-04
• Study First Submitted QC: 2006-01-04
• Study First Posted: 2006-01-09
• Study Start: 2006-02
• Study Completion: 2007-05
• Status Verified: 2011-01
• Last Update Submitted: 2011-01-21
• Last Update Posted: 2011-01-24

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 100

Inclusion Criteria

• Diagnosis of asthma >/= 3 months,
• Prescribed daily use of inhaled glucocorticosteroid

Exclusion Criteria

• Asthma exacerbation within the last month

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: CROSSOVER

Primary Outcome Measures

Name	Time	Method
ACQ

Secondary Outcome Measures

Name	Time	Method
Ability to follow prescription, AQLQ, lung function, No, eosinophil

Trial Locations

Locations (1)

Research Site; 🇩🇰 Copenhagen, Denmark